Skip to main content

US ClosedU.S. Closed

Healthcare · Biotechnology

Avalyn Pharma Inc. operates as a biopharmaceutical firm currently in its clinical development phase.

52W Range

59thpctl

Volume

0.43×avg

Market Cap

1.49BUSD

P/E Ratio

-26.0TTM

Div Yield

-ann

Loading chart data...

Current StateState loading

Avalyn Pharma Inc. Common Stock

AVLNNASDAQ Global Market·USD·Closed

Avalyn Pharma Inc. Common Stock

AVLNNASDAQ·USD·Closed

$33.57

−3.17%

$33.57

−$1.10 (3.17%)

52W Range

59thpctl

Volume

0.43×avg

Mkt Cap

1.49BUSD

P/E

-26.0TTM

Div Yield

–ann

AVLN: Avalyn Pharma Inc. Common Stock Stock Analysis | finqOS